Clinical trial
Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer
NCT02030769 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pronase Improves Efficacy of Chromoendoscopy Screening on Esophageal Cancer
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- December 31, 2014
- Enrollment
- 1,000 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.